TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Inovio Pharmaceuticals ( (INO) ) has issued an update.
On November 11, 2025, INOVIO Pharmaceuticals announced an underwriting agreement with Piper Sandler & Co. for a public offering of 13,158,000 shares of its common stock at $1.90 per share, with an option for underwriters to purchase an additional 1,973,700 shares, which was fully exercised. The offering is expected to generate approximately $26.5 million in net proceeds, with the closing anticipated around November 12, 2025, subject to customary conditions. This move aims to bolster INOVIO’s financial position and support its ongoing efforts in the biotechnology sector.
The most recent analyst rating on (INO) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Inovio Pharmaceuticals stock, see the INO Stock Forecast page.
Spark’s Take on INO Stock
According to Spark, TipRanks’ AI Analyst, INO is a Neutral.
Inovio Pharmaceuticals’ overall stock score is primarily impacted by its challenging financial performance, characterized by persistent losses and negative cash flows. Technical analysis indicates bearish momentum, and valuation metrics are weak due to ongoing losses. While the earnings call provided some positive developments, financial constraints remain a significant concern.
To see Spark’s full report on INO stock, click here.
More about Inovio Pharmaceuticals
INOVIO Pharmaceuticals is a biotechnology company focused on developing and commercializing DNA medicines to treat and protect against HPV-related diseases, cancer, and infectious diseases. The company specializes in optimizing the design and delivery of DNA medicines that enable the body to produce its own disease-fighting tools.
Average Trading Volume: 1,694,990
Technical Sentiment Signal: Sell
Current Market Cap: $115.2M
Learn more about INO stock on TipRanks’ Stock Analysis page.